findmyKOL
Clinical trialNCT00239980CompletedPhase 2Interventional

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

SponsorOntario Clinical Oncology Group (OCOG)Enrollment77Ovarian Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Cross Cancer Institute

    Edmonton, Alberta, Canada

  • B.C. Cancer Agency- Fraser Valley Centre

    Surrey, British Columbia, Canada

  • B.C. Cancer Agency- Vancouver Centre

    Vancouver, British Columbia, Canada

  • Nova Scotia Cancer Centre

    Halifax, Nova Scotia, Canada

  • Juravinski Cancer Centre

    Hamilton, Ontario, Canada

  • London Health Sciences Centre

    London, Ontario, Canada

  • the Ottawa Hospital Cancer Centre

    Ottawa, Ontario, Canada

  • Princess Margaret Hospital

    Toronto, Ontario, Canada

  • Hopital Notre-Dame

    Montreal, Quebec, Canada

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2005
Primary completion
31 Jan 2010
Completion
31 Jan 2010
Last update posted
3 Feb 2010
Registered enrollment
77
Registry id
NCT00239980

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.